Form D · Biotechnology
Ocunexus Therapeutics, Inc.
San Diego, CA · CIK 0001378567
Offering snapshot reported Jan 13, 2021 · SEC filing
- Reported sold
- $9.13M Offering amount: $9.13M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 30, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 13, 2021 | Initial | $9,125,807 | No comparison | 3 | SEC filing |
| Jun 15, 2016 | Initial | $753,986 | No comparison | 2 | SEC filing |
| Jun 15, 2015 | Initial | $1,206,379 | No comparison | 2 | SEC filing |
| Feb 19, 2015 | Initial | $1,002,656 | No comparison | 2 | SEC filing |
| Jun 10, 2014 | Initial | $2,510,890 | No comparison | 2 | SEC filing |
| Aug 1, 2012 | Initial | $19,400,000 | No comparison | 1 | SEC filing |
| May 13, 2011 | Initial | $19,200,000 | No comparison | 4 | SEC filing |
| Oct 11, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-386220
Amounts paid pursuant to conversion of indebtedness.
Source: Form D, filed Jan 13, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Blair | Director |
| Geoff Brooke | Director |
| Bradford Duft | Director, Executive |
| Inna Martin Eitan | Director |
| Mikhail Getman | Director |
| Anton Gopka | Director |
| Colin Green | Director |
| Howard "Ted" Greene | Director |
| Howard Greene, Jr. | Director |
| Brian Levy | Director, Executive |
| James Mervis | Director |
| David Pool | Executive |
| Pavel Rodyukov | Director |
| Peter Thompson | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12481 High Bluff Drive, Suite 150
San Diego, CA, 92130
San Diego, CA, 92130